Michael W. Deininger

2 ta ish

Guy's and St Thomas' NHS Foundation Trust

1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

   Andreas Hochhaus, Michele Baccarani, Richard T. Silver +31

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.108182

2. POSTER: CML-319 Molecular Response of ≤10% BCR::ABL1IS Is Predictive of Positive Outcomes in Patients With Treatment-Resistant Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Treated With Ponatinib From the Phase 2 OPTIC Trial

   Jane F. Apperley, Jörge E. Cortes, Elias Jabbour +21

   MaqolaOAOchiq kirishChronic Myeloid Leukemia TreatmentsClinical Lymphoma Myeloma & Leukemia20230 iqtibos

   ABIABI:AkademIndex/2023.article.010140